ABSTRACT
AIM: The aim of this study is to determine the levels of spike protein IgG and total antibodies in subjects vaccinated against SARS-CoV-2 (both infected and non-infected) and the titer evolution over time. In addition, we also addressed the performance of each of the included platforms in the study, as they are intended to measure antibody levels in naturally infected patients. MATERIALS AND METHODS: An observational study including 288 volunteer healthcare professionals vaccinated against SARS-CoV-2 (Comirnaty™) at the Andújar Alto Guadalquivir Hospital. Serum samples were obtained in September 2020 and 14 and 90 days after administration of the second dose. The following in vitro methods were used: Elecsys Anti-SARS-CoV-2 N and Elecsys Anti-SARS-CoV-2 S (Roche, Germany) and EliA SARS-CoV-2-Sp1 IgG (Thermo Fisher Scientific, Germany). RESULTS: For the Elecsys S method at 1/10 dilution and for the EliA Sp1 IgG method at 1/5 dilution, 54% and 19% of samples were out of range, respectively. The vaccine activated a high humoral response- 0 to 3000 BAU/mL being the "normal titer range" in all volunteers. Patients vaccinated after COVID-19 exhibited higher total S antibody load values than non-vaccinated volunteers while showing the same response for S IgG isotype. Titers decreased up to 86% in the case of S IgG neutralizing antibodies. CONCLUSIONS: The characterization of human response to SARS-CoV-2 vaccines is still far from being completely elucidated. It is important to increase the methods dynamic range to study humoral response evolution in depth and decide whether booster doses or seasonal vaccination plans will be necessary to definitively control the pandemic.
Subject(s)
COVID-19 Vaccines , COVID-19 , Humans , SARS-CoV-2 , COVID-19/prevention & control , Antibodies, Viral , Immunoglobulin G , Delivery of Health CareSubject(s)
Eosinophilic Esophagitis/pathology , Eosinophils/physiology , Esophagus/pathology , Adolescent , Adult , Biopsy , Endoscopy , Humans , Male , Middle Aged , Mucous Membrane/pathology , Predictive Value of Tests , Young AdultABSTRACT
We present a case of septicaemia caused by Arcanobacterium haemolyticum in a previously healthy 23-year-old man suffering from acute pharyngotonsillitis, who developed complicated Lemierre's syndrome. Three blood cultures (both aerobic and anaerobic) revealed the exclusive presence of A. haemolyticum. The presence of Fusobacterium necroforum was not essential for the development of this pathology. To our knowledge, this is the first reported case of Lemierre's syndrome caused solely by A. haemolyticum. We confirm that this organism must be considered a potential pathogen in immunocompetent patients.
Subject(s)
Actinomycetales Infections/complications , Arcanobacterium/isolation & purification , Sepsis/microbiology , Venous Thrombosis/microbiology , Acenocoumarol/therapeutic use , Actinomycetales Infections/drug therapy , Actinomycetales Infections/pathology , Anti-Bacterial Agents/therapeutic use , Anticoagulants/therapeutic use , Brain Abscess/microbiology , Brain Abscess/pathology , Humans , Jugular Veins/pathology , Male , Sepsis/drug therapy , Young AdultABSTRACT
La enfermedad de Kikuchi Fujimoto (EKF) es, desde el punto de vista histológico una linfadenitis necrotizante de evolución clínica autolimitada. Afecta típicamente a los ganglios linfáticos, cursando a menudo con fiebre alta. En el presente trabajo se documenta el caso de un varón de 28 años portador de una EKF, compatible clínicamente con un tumor de glándula salival. Ecográficamente llegaba a plantearse el diagnóstico diferencial con un quiste branquial. En general, debe plantearse este diagnóstico también con el linfoma (AU)
